MATERIALS:
Starting materials, reagents, and solvents were purchased from commercial suppliers (Sigma-Aldrich, Acros, and Fisher) and used as received unless otherwise noted. All reactions were conducted in flame-dried glassware with magnetic stirring under an atmosphere of dry nitrogen.
METHODS: Nanoparticle Synthesis
The synthesis of ZnFe 2 O 4 magnetic nanoparticles (MNPs) has previously been reported and modified by our group. [1, 2] Typically, 300 mg ZnCl 2 , 400 g FeCl 2 , and 3.5 g Fe(acac) 3 were mixed in 50 mL of tri-octylamine. Next, 1.2 mL oleic acid was added and refluxed at 300°C in a 250 mL three necked round bottom flask. After one hour, the reaction mixture was cooled to room temperature and the MNPs were precipitated using ethanol. The MNPs were then purified by repeated centrifugation and sonication. Afterwards, the as obtained nanoparticles were dried overnight under vacuum. To convert the hydrophobic MNPs into hydrophilic MNPs, a ligand exchange reaction was carried out using 2, 3 -dimercaptosuccinic acid (DMSA). [3, 4] In a typical experiment, 5 g of DMSA was dissolved in chloroform and added to a solution containing 40 mg of oleic acid/oleyl amine coated MNPs in toluene. The resulting mixture/solution was allowed to react for 24 hrs at room temperature with continuous stirring.
The nanoparticles were then collected by centrifugation and dried under vacuum. The dried nanoparticles were then re-dispersed in DPBS (pH 7.4), to obtain an aqueous solution of MNPs with the desired concentration.
Formation of MNP-PEI/miRNA/PEI complexes
To prepare the aforementioned ZnFe 2 O 4 MNPs for microRNA (miRNA) delivery, t he negatively c harged water-soluble MNPs were coated w ith a branched cationic polymer, polyethyleneimine (PEI), which affords the MNPs with an overall positive charge. PEI is a polymer that is partially protonated under physiological conditions, thus allowing for the formation of complexes in the presence of nucleic acids. [5] PEIs have been used extensively for the delivery of DNA plasmids and other DNA and RNA molecules including small interfering RNA (siRNA) and m iRNA. [5] [6] [7] Specifically, it has been demonstrated that PEI-based complexes are able to enter the cell via caveolae-or clathrin-dependent routes and are able to facilitate release from the endosome with high efficiency via the "proton sponge effect." [8] To obtain PEI coated MNPs, the water soluble MNPs were first diluted with DPBS to reach a final concentration of 0.1 mg/mL. Afterwards, excess 10 kDa branched PEI (Sigma Aldrich) was added drop wise (1 mg/mL). This molecular weight (MW) and structure of PEI was chosen based on previous reports. [9] After spinning overnight, the PEI coated MNPs were filtered using a centrifugal filter unit (EMD Millipore, 10,000 MW) to remove excess PEI. To complex the PEI coated MNPs with miRNA, MNP-PEI were diluted in 80 mM NaCl solution and 100 nM miRNA was added to the solution. Specifically, the NaCl solution was necessary to overcome repulsive forces and to wrap the miRNA and PEI polymer around the small MNPs. [10] It should also be noted that all miRNAs were purchased from Ambion in the pre-miRNA form (~70 nucleotides): Pre-miR miRNA Precursor let-7a (PM10050), Pre-miR miRNA Precursor Negative Control #1 (AM17110), and Cy3 dye-labeled Pre-miR Negative Control #1 (AM17120). After 20 minutes of complex formation at room temperature, 1 uL of 1 mg/mL PEI was added and the samples were incubated for an additional 20 minutes. After the incubation was completed, the samples were once again filtered using a centrifugal filter unit (EMD Millipore, 10,000 MW) to remove excess PEI. To determine the initial concentration of MNP-PEI that needed to be added to complex 100 nM of miRNA, complexes with increasing concentrations of MNP-PEI were incubated with 100 nM miRNA. Afterwards, respectively. All measurements were corrected for background fluorescence from a solution containing only buffer and PicoGreen dye. Similarly, to determine the concentration of NaCl solution used in complexing, complexes were prepared as described above utilizing different concentrations of NaCl solution (40, 80, 120 mM) and the size of t he complexes was determined using dynamic light scattering (DLS).
Nanoparticle Complex Characterization
Dynamic light scattering (DLS) and Zeta Potential analyses were performed using a Malvern Instruments Zetasizer Nano ZS-90 instrument (Southboro, MA) with reproducibility being verified by t he collection and comparison of s equentially o btained measurements.
Nanoparticle/miRNA complexes (miRNA concentration = 100 nM), were prepared using purified water (resistivity = 18.5 MΩ-cm). DLS measurements were performed at a 90° scattering angle at 25°C. Z-average sizes of three sequential measurements were collected and analyzed. Zeta potential measurements were collected at 25°C, and the Z-average potentials following three sequential measurements were collected and analyzed.
Transfection of Cell Lines with MNP complexes
Twenty-four hours before the magnetofection of MNP complexes, 30,000 brain cancer cells (in a volume of 500 uL) were seeded into each well of a 12-well plate, so as to attain 80% confluency at the time of transfection. MNP-PEI/miRNA/PEI complexes were formed as described above. Thereafter the MNP complexes were mixed with Opti MEM (Life Technologies) and added to each well to attain the desired final concentration of miRNA/well. Subsequently, the cell culture plates were placed on an Nd-Fe-B magnetic plate (OZ Biosciences, France) for 10 minutes (as optimized from previous reports). [1] The culture plates were placed back into the incubator for 5 hrs and afterwards, the cells were washed with DPBS and the transfection medium was replaced with fresh growth medium. The growth mediums for the cell lines (obtained from ATCC) used in the study are as follows: U87-EGFRvIII (DMEM supplemented with 10% FBS, 1% Penicillin-Streptomycin, 1% Glutamax, and hygromycin B as a selection marker) as well as U87-WT, U87-EGFR, and Astrocytes (DMEM supplemented with 10% FBS, 1% Penicillin-Streptomycin).
Magnetic Hyperthermia
Twenty-four hours after seeding cells as described above, 10 μg/mL of PEI-MNPs were prepared in Opti MEM (Life Technologies) and added to each well. Subsequently, the cell culture plates were exposed to magnetofection for 10 minutes as described above. The culture plates were placed back into the incubator for 5 hrs and afterwards, the cells were washed with DPBS and the transfection medium was replaced with fresh growth medium. Twenty-four hours after transfection, cells were washed with DPBS, trypsanized, and exposed to an alternating magnetic field (5 kA/m, 225 kHz) for the desired amount of time. Thereafter, fresh media was added to the treated cells and the cells were plated back into 12-well plates.
Combined MNP-based miRNA delivery and magnetic hyperthermia MNP-PEI/let-7a/PEI complexes were delivered to U87-EGFRvIII GBM cells 24 hrs after seeding. Next, cells were trypsinized and exposed to an alternating magnetic field to induce magnetic hyperthermia 24 hrs after transfection and cell viability was quantified 48 hrs after initial transfection.
Cell Viability Assays
The percentage of viable cells was determined by MTS assay following standard protocols as described by the manufacturer. All measurements were made 48 hrs after initial transfection.
All experiments were conducted in triplicate and averaged. The data is represented as formazan absorbance at 490 nm, considering the control (untreated) cells as 100% viable. To assay apoptosis using Annexin V-FLUOS and Propidium Iodide staining (Roche), 48 hrs after initial transfection, 10 6 cells were prepared in 1 mL of PBS with 10% FBS in each test tube.
After centrifugation, cells were resuspended in 100 μl Annexin V Binding Buffer (ice-cold) and Annexin V-FLUOS and Propidium Iodide (PI) were added following the manufacturers recommendation. Samples were incubated in the dark for 15 minutes at room temperature.
Finally, 400 μl of additional ice-cold Annexin V Binding Buffer was added and the samples were kept on ice, under foil until analysis using flow cytometry.
qPCR Analysis
To quantify the effect that miRNA delivery had, we quantified the mRNA expression levels, as it has been reported that mammalian miRNAs primarily regulate target genes by decreasing mRNA levels. [11] Total RNA was extracted 48 hrs after initial transfection using Trizol Reagent (Life Technologies) and the mRNA expression level of target genes (Table S1) Table S1 ).
Tumor Spheroid Monoculture Assay
Tumor spheroid monocultures of U87-EGFRvIII cells were formed using the hanging drop method. Specifically, adherent U87-EGFRvIII cell cultures were first grown to 90% confluence after which they were rinsed with PBS and tryspinized (0.05% trypsin-1 mM EDTA). Trypsinization was halted using complete medium and the cell suspension was centrifuged at 200 XG for 5 minutes. Afterwards, the supernatant was discarded and the pellet was resuspended in 1 mL of media. Cells were counted using a hemacytometer and the cell concentration was adjusted to 1 x 10 6 cells/mL. To form hanging drops, the lid of a 6 cm cell culture dish was removed and 20 ul drops of cell suspension were placed on the bottom of the lid. The lid was then inverted into a PBS-filled bottom chamber and incubated at 37°C for 24 hours. Finally, after 24 hours, each spheroid was transfered to separate wells of a 24-well plate.
Animal Studies

5-6
week old nu/nu mice were used for the in vivo experiments. SUM159 breast cancer cells were cultured under standard conditions. 2 x 10 6 SUM159 breast cancer cells were subcutaneously inoculated into the dorsal part of the mice. Tumors were allowed to develop for 2 weeks after which MNPs (25 and 50 mg/kg of body weight) were injected via tail vein injection. Specifically, MNPs (DMSA-capped) were conjugated with PEI (10 kDa, branched) via electrostatic interaction. Afterwards, the amine groups of the PEI were conjugated with the carboxyl group of poly(ethylene glycol) (PEG; MW = 2,000; COOH-PEG-COOH) using EDC coupling. The other carboxyl group was conjugated with anti-CD44, again, using EDC coupling. Finally, cy3-NHS was conjugated onto the nanoparticles (NHS binds to the amine groups of PEI). Images were taken up to a week after injection (IVIS system) after which, the mice were euthanized and the tumors were harvested. All in vivo animal procedures were approved by the Laboratory Animal Services at Rutgers University. Figure S1 : Optimization of magnetic nanoparticle complex formation S-7 Figure S2 : Cell uptake of magnetic nanoparticles complexes S-8 Figure S3 : Cell uptake of magnetic nanoparticles S-9 Figure S4 : Biocompatibility of MNP complexes S-10 Figure S5 : mRNA expression levels after the delivery of let-7a using magnetic nanoparticles S-11 Figure S1: Optimization of magnetic nanoparticle complex formation. (a) To determine the optimal molecular weight of PEI for miRNA delivery, we coated out MNPs with 2 kDa, 10 kDa, and 25 kDa, following the same protocol. We found that while 2 kDa PEI coated MNPs had the lowest cytotoxicity, 10 kDa had a significantly higher transfection efficiency. (b) A reversal in the zeta potential is observed after the addition of each layer. (c) To determine the NaCl concentration that should be used in the solution during complexing, 3 different NaCl concentrations were tested. Afterwards, the overall diameter of the complexes was measured using DLS. The results demonstrate that 80 mM NaCl solution worked best for layer-by-layer complex formation. (d) To determine the minimum concentration of MNP that was needed to bind 100% of the miRNA, a PicoGreen dye was used. It was found that 1 μg/mL MNP was sufficient to bind nearly 100% of the miRNA. 24 hours after spheroid formation, individual spheroids were transferred to 24-well plates and exposed to the varying treatment conditions (same as those utilized in the monolayer cell culture condition). Cell viability following combined let-7a delivery and magnetic hyperthermia as quantified by MTS assay demonstrates that combined therapy remains effective even on tumor spheroids albeit expectedly less effective compared to monolayer cultures. Conditions were normalized to scrambled microRNA as delivered by MNPs (*p < 0.05, **p < 0.01).
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Figure S10:
In vivo biodistribution of MNP complexes. (a) 2 x 10 6 SUM159 breast cancer cells were subcutaneously inoculated into the dorsal part of 5-6 week old nu/nu mice. Tumors were allowed to develop for 2 weeks after which cy3-conjugated MNPs that were coated with PEI-PEG and targeted via anti-CD44 antibody were injected via tail vein injection (25 and 50 mg/kg of body weight). Images were taken over the following week and mice were euthanized one week after MNP injection. (b) Table explaining the different treatment groups. There were 5 groups with 5 animals in each group. (c) Tumor volume was monitored over the entire study (d) Tumor weight was also quantified after tumor collection. (d) Representative images taken using an IVIS system confirm that the cy3-conjugated MNPs (with and without targeting) were able to localize within the tumor within 1 week after MNP injection. Reverse Primer   AURKA  TTCAGGACCTGTTAAGGCTACA  CGAGAACACGTTTTGGACCTC   AURKB  CGCAGAGAGATCGAAATCCAG  AGTTGTAGAGACGCAGGATGTT  BRCA1  GGCTATCCTCTCAGAGTGACATTT  GCTTTATCAGGTTATGTTGCATGG  BRCA2  CTAATTAACTGTTCAGCCCAGT  CTAGAACATTTCCTCAGAATTGTC  CASP3  AGAACTGGACTGTGGCATTGA  GCTTGTCGGCATACTGTTTCAG   CDK4  AGAGTGTGAGAGTCCCCAATG  CGCCTCAGTAAAGCCACCT  GRB2  CTGGGTGGTGAAGTTCAATTCT  GTTCTATGTCCCGCAGGAATATC   HRAS  GACGTGCCTGTTGGACATC  CTTCACCCGTTTGATCTGCTC   HSP27  TGGACCCCACCCAAGTTTC  CGGCAGTCTCATCGGATTTT   HSP70  TTTTACCACTGAGCAAGTGACTG  ACAAGGAACCGAAACAACACA   HSP72  TGCTGATCCAGGTGTACGAG  CGTTGGTGATGGTGATCTTG   HSP90  AGGTGTTTATACGGGAGCTGA  GCATTGGTCTGCAAGTGAATCTC  HMGA2  CAGCAGCAAGAACCAACCG  GGTCTTCCCCTGGGTCTCTTA  IGF1R  CTCCTGTTTCTCTCCGCCG  ATAGTCGTTGCGGATGTCGAT   KRAS  AGCGTCACTGGCACTTTCAAA  CACCCACATAGAAGACCTGGT  MYC  CTCCTCACAGCCCACTGGTC  CTTGGCAGCAGGATAGTCCTTC  NRAS  TGAGAGACCAATACATGAGGACA  CCCTGTAGAGGTTAATATCCGCA  P53 TTTGCGTGTGGAGTATTTGGAT CAACCTCAGGCGGCTCATA PI3K GAAACAAGACGACTTTGTGACCT CTTCACGGTTGCCTACTGGT Table S1 : Table of primers used for qPCR. All primers were obtained from the PrimerBank database. [12] [13] [14] 
Forward Primer
